Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Clinical trial NCT07682896 · RECRUITING
Trial details
- NCT number
- NCT07682896
- Sponsor
- Yarrow Bioscience, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-10
- Primary completion
- 2027-12-01
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.